This archive contains the following articles listed by volume, issue and page number:
 |
|
|
OPHTHALMICS RELATED ARTICLES |
Title (Click for Details) |
Vol/Issue |
Page |
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants |
Vol. 24 No. 5 |
388 |
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions |
Vol. 24 No. 5 |
420 |
Calculations |
Vol. 24 No. 2 |
128 |
Acetazolamide 25 mg/mL in SyrSpend SF pH4 |
Vol. 24 No. 2 |
130 |
Compatibility of Melphalan in Iodinated Contrast Media |
Vol. 24 No. 1 |
83 |
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% |
Vol. 23 No. 5 |
418 |
Calculations |
Vol. 22 No. 5 |
406 |
Cysteamine 0.5% Ophthalmic Solution |
Vol. 22 No. 5 |
408 |
Dorzolamide 2% Ophthalmic Solution |
Vol. 22 No. 3 |
234 |
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution |
Vol. 22 No. 2 |
147 |
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations |
Vol. 21 No. 6 |
481 |
Tacrolimus 0.3-mg/mL Ophthalmic Solution |
Vol. 21 No. 5 |
416 |
Calculations |
Vol. 21 No. 4 |
310 |
Tacrolimus 0.06% Ophthalmic Drops |
Vol. 21 No. 4 |
319 |
Ofloxacin 0.3% Ophthalmic Solution |
Vol. 21 No. 3 |
236 |
Infliximab 1% Ophthalmic Solution |
Vol. 21 No. 1 |
62 |
Tetracaine Hydrochloride 0.5% Ophthalmic Solution |
Vol. 21 No. 1 |
64 |
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments |
Vol. 20 No. 6 |
495 |
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions |
Vol. 20 No. 5 |
399 |
Gatifloxacin 0.5% Ophthalmic Solution |
Vol. 20 No. 4 |
319 |
Plasmingen and Hyaluronate Sodium Ophthalmic Solution |
Vol. 20 No. 4 |
325 |
Scopolamine Hydrobromide 0.25% Ophthalmic Solution |
Vol. 20 No. 4 |
326 |
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment |
Vol. 20 No. 3 |
228 |
Calculations |
Vol. 20 No. 1 |
46 |
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment |
Vol. 20 No. 1 |
51 |
Tropicamide 1% Ophthalmic Solution |
Vol. 20 No. 1 |
55 |
Vancomycin 5% and Amikacin 2% Ophthalmic Solution |
Vol. 20 No. 1 |
56 |
Voriconazole 10-mg/mL Ophthalmic Solution |
Vol. 20 No. 1 |
57 |
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate |
Vol. 19 No. 6 |
508 |
Proparacaine Hydrochloride 0.5% Ophthalmic Solution |
Vol. 19 No. 4 |
332 |
Atropine Sulfate 1% Ophthalmic Solution |
Vol. 19 No. 3 |
242 |
Protocol of Blood Serum Eye Drops |
Vol. 19 No. 3 |
252 |
Physostigmine Salicylate 1-mg/mL Injection |
Vol. 19 No. 2 |
150 |
Trypan Blue 0.06% Ophthalmic Solution |
Vol. 19 No. 2 |
151 |
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration |
Vol. 19 No. 1 |
70 |
Methazolamide 25-mg or 50-mg Capsules |
Vol. 18 No. 6 |
499 |
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report |
Vol. 18 No. 5 |
370 |
Fluorescein 100-mg/mL Injection |
Vol. 18 No. 5 |
412 |
Indocyanine green 2.5-mg/mL Injection |
Vol. 18 No. 5 |
413 |
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution |
Vol. 18 No. 5 |
414 |
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation |
Vol. 18 No. 5 |
418 |
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution |
Vol. 17 No. 6 |
502 |
Calculations |
Vol. 17 No. 1 |
62 |
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease |
Vol. 16 No. 3 |
190 |
Cefepime 1% Ophthalmic Solution |
Vol. 15 No. 6 |
500 |
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution |
Vol. 15 No. 6 |
507 |
Vancomycin 31-mg/mL Ophthalmic Solution |
Vol. 15 No. 6 |
508 |
Gramicidin 13% Ophthalmic Solution |
Vol. 14 No. 6 |
519 |
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution |
Vol. 14 No. 5 |
421 |
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together |
Vol. 14 No. 4 |
270 |
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops |
Vol. 14 No. 4 |
336 |
Bacitracin 10,000-Units/mL Ophthalmic Solution |
Vol. 14 No. 3 |
240 |
Ophthalmic Toning-Lubricating Drops |
Vol. 14 No. 1 |
70 |
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution |
Vol. 14 No. 1 |
74 |
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis |
Vol. 13 No. 6 |
506 |
Calculations |
Vol. 13 No. 6 |
545 |
Cidofovir 0.2-mg/mL Intravitreous Injection |
Vol. 13 No. 6 |
554 |
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops |
Vol. 13 No. 6 |
540 |
Miconazole 1% Ophthalmic Solution, Veterinary |
Vol. 13 No. 6 |
559 |
Voriconazole 2% Ophthalmic Solution |
Vol. 13 No. 6 |
562 |
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes |
Vol. 13 No. 6 |
564 |
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution |
Vol. 12 No. 5 |
456 |
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration |
Vol. 12 No. 1 |
8 |
Calculations: High-Technology Compounding and Investigational Dispensing |
Vol. 11 No. 6 |
500 |
Interferon alfa-2b Ophthalmic Solution |
Vol. 11 No. 6 |
510 |
Carbidopa 1.25-mg/mL Oral Liquid |
Vol. 11 No. 1 |
70 |
Compounding for Feline Herpetic Keratitis |
Vol. 10 No. 6 |
411 |
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions |
Vol. 10 No. 3 |
218 |
Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 |
Vol. 8 No. 5 |
359 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 |
Vol. 8 No. 4 |
277 |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 |
Vol. 8 No. 3 |
169 |
Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 8 No. 3 |
185 |
Fluorouracil 1% Ophthalmic Solution |
Vol. 8 No. 3 |
217 |
Netilmicin 0.455% Ophthalmic Solution |
Vol. 8 No. 2 |
138 |
Bacitracin 500-U/g Ophthalmic Ointment |
Vol. 7 No. 6 |
467 |
Chloramphenicol 0.5% Ophthalmic Solution |
Vol. 7 No. 6 |
468 |
Dexamethasone Phosphate 0.05% Ophthalmic Ointment |
Vol. 7 No. 3 |
215 |
Epinephrine Bitartrate 2% Ophthalmic Solution |
Vol. 7 No. 3 |
218 |
Erythromycin and Dexamethasone Ophthalmic Solution |
Vol. 6 No. 6 |
452 |
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL |
Vol. 5 No. 4 |
300 |
Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution |
Vol. 5 No. 4 |
301 |
Hyaluronidase Injection |
Vol. 5 No. 4 |
303 |
Phenylephrine 0.25% Ophthalmic Solution, Preservative Free |
Vol. 5 No. 4 |
307 |
Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution |
Vol. 5 No. 4 |
309 |
Mitomycin 0.02% Ophthalmic Solution |
Vol. 5 No. 3 |
209 |
Tetracycline HCl 1% Ophthalmic Ointment |
Vol. 5 No. 3 |
212 |
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution |
Vol. 5 No. 3 |
213 |
Artificial Tears for Dry Eyes |
Vol. 4 No. 5 |
376 |
Interferon Ophthalmic Solution |
Vol. 4 No. 5 |
380 |
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution |
Vol. 4 No. 4 |
320 |
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution |
Vol. 4 No. 2 |
146 |
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution |
Vol. 3 No. 4 |
316 |
Compounding Ophthalmic Preparations |
Vol. 2 No. 3 |
184 |
Isotonic Sodium Chloride Solution Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
Boric Acid Solution Vehicle for Ophthalmic Preparations |
Vol. 2 No. 3 |
188 |
Boric Acid Solution Vehicle without Benzalkonium Chloride for Ophthmalic Preparations |
Vol. 2 No. 3 |
188 |
Phosphate Buffer System Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
Ophthalmic Compounding: Techniques for Achieving Sterility |
Vol. 2 No. 3 |
189 |
Buffer Solutions for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Palitzsch Buffer Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sodium Acetate-Boric Acid-Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sorensen's Modified Phosphate Buffer-Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Sorensen's Modified Phosphate Buffer- Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Acid Stock Solution |
Vol. 2 No. 3 |
190 |
Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
Feldman Buffer for Ophthalmic Preparations-Acid Stock Solution |
Vol. 2 No. 3 |
190 |
Feldman Buffer for Ophthalmic Preparations-Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
Gilford Ophthalmic Buffer-Acid Stock Solution |
Vol. 2 No. 3 |
191 |
Gilford Ophthalmic Buffer-Alkaline Stock Solution |
Vol. 2 No. 3 |
191 |
Anatomy of the Eye |
Vol. 2 No. 3 |
191 |
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations |
Vol. 2 No. 3 |
192 |
Ophthalmic Solutions in Cataract Surgery |
Vol. 2 No. 3 |
196 |
Veterinary Dexamethasone 0.1% Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
Veterinary 2-deoxy-D-glucose Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
Ophthalmic Compounding for Animals - Equine Ophthalmic Ointments and Treatment of Epithelial Calcification of the Cornea with EDTA 1% |
Vol. 2 No. 3 |
206 |
Eyecups: The Beginning of Eye Irrigation and Treatment |
Vol. 2 No. 3 |
208 |
Acetylcysteine 15% Ophthalmic Solution |
Vol. 2 No. 3 |
222 |
Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
223 |
Ascorbic Acid 10% Ophthalmic Solution |
Vol. 2 No. 3 |
224 |
Calcium Gluconate 1% Ophthalmic Irrigation Solution |
Vol. 2 No. 3 |
225 |
Cyclosporine 2% Ophthalmic Solution |
Vol. 2 No. 3 |
226 |
Dexamethasone Sodium Phosphate 0.05% Ophthalmic Ointment |
Vol. 2 No. 3 |
227 |
Fluconazole 0.2% Ophthalmic Solution |
Vol. 2 No. 3 |
228 |
Fortified Gentamicin Ophthalmic Solution |
Vol. 2 No. 3 |
229 |
Glucose 40% Ophthalmic Ointment |
Vol. 2 No. 3 |
230 |
Idoxuridine 0.5% Ophthalmic Ointment |
Vol. 2 No. 3 |
231 |
Idoxuridine 0.1% Ophthalmic Solution |
Vol. 2 No. 3 |
232 |
Lissamine Green 0.5% Ophthalmic Solution |
Vol. 2 No. 3 |
233 |
Ophthalmic Lubricant |
Vol. 2 No. 3 |
234 |
Rose Bengal 1% Ophthalmic Solution |
Vol. 2 No. 3 |
235 |
Vancomycin 25-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
236 |
Sorption of Benzalkonium Chloride to Various Filters Used in Ophthalmics |
Vol. 2 No. 3 |
249 |
Acetylcysteine 10% Ophthalmic Solution |
Vol. 1 No. 5 |
320 |
Tropicamide-Hydroxyamphetamine Hydrobromide Ophthalmic Solution |
Vol. 1 No. 5 |
335 |